ArticleScientific reports2024

Cardiovascular adverse events and immune-related adverse events associated with PD-1/PD-L1 inhibitors for head and neck squamous cell carcinoma (HNSCC).

Adila Abulizi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.